Pseudo-Hurler polydystrophy

Pseudo-Hurler Polydystrophy is a rare genetic disorder characterized by progressive physical disability and mental deterioration. It is also known as Mucolipidosis III (ML III).

Symptoms

The symptoms of Pseudo-Hurler Polydystrophy typically become apparent in early childhood and may include mild to moderate intellectual disability, skeletal abnormalities, and progressive physical disability. Affected individuals may also have coarse facial features, including a broad nose, thick lips, and enlarged tongue, as well as clouding of the corneas and hearing loss.

Causes

Pseudo-Hurler Polydystrophy is caused by mutations in the GNPTAB gene. This gene provides instructions for making an enzyme that is involved in the breakdown and recycling of large sugar molecules called glycosaminoglycans (GAGs). Mutations in the GNPTAB gene disrupt the normal function of this enzyme, leading to the accumulation of GAGs in cells throughout the body. This accumulation is believed to contribute to the signs and symptoms of Pseudo-Hurler Polydystrophy.

Diagnosis

Diagnosis of Pseudo-Hurler Polydystrophy is based on a clinical examination, detailed patient history, and specialized tests. These tests may include enzyme assays, genetic testing, and imaging studies to assess the extent of skeletal abnormalities.

Treatment

There is currently no cure for Pseudo-Hurler Polydystrophy. Treatment is symptomatic and supportive, and may include physical therapy, special education, and medications to manage pain and other symptoms. In some cases, surgery may be necessary to address skeletal abnormalities.

See Also

• Mucolipidosis
• Genetic Disorders
• Glycosaminoglycans
• GNPTAB gene

References

• National Organization for Rare Disorders
• Genetics Home Reference
• National Institutes of Health

Pseudo-Hurler polydystrophy Resources
Latest articles Most recent articles Ongoing trials	Wikipedia